Nucleic Acids Research, 2003, Vol. 31, No. 12 3267-3273
© 2003 Oxford University Press
Triplex formation with 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) having C3'-endo conformation at physiological pH
Exploratory Chemistry Research Laboratories, 1 Biomedical Research Laboratories and 2 Pharmacokinetics and Drug Delivery Research Laboratories, Sankyo Co. Ltd, Tokyo 140-8710, Japan and 3 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan
*To whom correspondence should be addressed. Tel: +81 3 3492 3131; Fax: +81 3 5436 8570; Email: koizum{at}shina.sankyo.co.jp
This paper is dedicated to the memory of the late Professor Claude Hélène.
Antigenes, which are substances that inhibit gene expression by binding to double-stranded DNA (dsDNA) in a sequence-specific manner, are currently sought for the treatment of various gene-related diseases. As such antigenes, we developed new nuclease-resistant oligopyrimidine nucleotides that are partially modified with 2'-O,4'-C-ethylene nucleic acids (ENA), which are constrained in the C3'-endo conformation and can form a triplex with dsDNA at physiological pH. It was found that these oligonucleotides formed triplexes similarly to those partially modified with 2'-O,4'-C-methylene nucleic acids (2',4'-BNA or LNA), as determined by UV melting analyses, electromobility shift assays, CD spectral analyses and restriction enzyme inhibition assays. In our studies, oligonucleotides fully modified with ENA have
torsion angle values that are marginally higher than those of 2',4'-BNA/LNA. ENA oligonucleotides present in 10-fold the amount of dsDNA were found to be favorable in forming triplexes. These results provide useful information for the future design of triplex-forming oligonucleotides fully modified with such nucleic acids constrained in the C3'-endo conformation considering that oligonucleotides fully modified with 2',4'-BNA/LNA do not form triplexes.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Brunet, M. Corgnali, F. Cannata, L. Perrouault, and C. Giovannangeli Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment Nucleic Acids Res., September 11, 2006; 34(16): 4546 - 4553. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brunet, M. Corgnali, L. Perrouault, V. Roig, U. Asseline, M. D. Sorensen, B. R. Babu, J. Wengel, and C. Giovannangeli Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities Nucleic Acids Res., July 27, 2005; 33(13): 4223 - 4234. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brunet, P. Alberti, L. Perrouault, R. Babu, J. Wengel, and C. Giovannangeli Exploring Cellular Activity of Locked Nucleic Acid-modified Triplex-forming Oligonucleotides and Defining Its Molecular Basis J. Biol. Chem., May 20, 2005; 280(20): 20076 - 20085. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Sorensen, J. T. Nielsen, and M. Petersen Solution structure of a dsDNA:LNA triplex Nucleic Acids Res., November 18, 2004; 32(20): 6078 - 6085. [Abstract] [Full Text] [PDF] |
||||

